Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

计划入组 82 人 · 首次发布于 2014 年 10 月 20 日

DSD Models at Zambia Sentinel Sites (SENTINEL 2)

计划入组 8,280 人 · 首次发布于 2023 年 6 月 15 日

DSD Models at Malawi Sentinel Sites (SENTINEL 2-Malawi)

计划入组 15,520 人 · 首次发布于 2023 年 6 月 13 日

p70S6 kinase inhibitors (Sentinel Oncology)

PMTA (Sinfonia Biotherapeutics)

HtrA1 inhibitor (Perceive Biotherapeutics)

Brain Sentinel, Inc.

United States

EXCISION BIOTHERAPEUTICS

United States

Arcutis Biotherapeutics

United States

Sentinel BioTherapeutics Launches with Novel IL-2 Immunotherapy Platform for Solid Tumors

Elite Pharmaceuticals Gains FDA Approval for Generic Vyvanse

Vaxart's Oral COVID-19 Vaccine Candidate Receives Positive DSMB Review, Advancing Phase 2b Trial